Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutated EPHA2 is a target for combating lymphatic metastasis in intrahepatic cholangiocarcinoma

9 Nov 2018

Abstract excerpt

Exploring the genetic aberrations favoring metastasis is important for understanding and developing novel strategies to combat cancer metastasis. It remains lack of effective treatment for the dismal prognosis of intrahepatic cholangiocarcinoma (ICC). Here, we aimed to study genetic alternations during lymph node metastasis of ICC and investigate potential mechanisms and clinical strategy focused on mutations. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Cancer-related gene regulation
Share to Cholangiocarcinoma and Gallbladder Cancer Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30412282
DOI: 10.1002/ijc.31979

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutated EPHA2 is a target for combating lymphatic metastasis in intrahepatic cholangiocarcinomaPMID 30412282Read ↗

Comprehensive Analysis of Genomic Mutation Signature and Tumor Mutation Burden for Prognosis of Intrahepatic CholangiocarcinomaSemantic proximity Read ↗

Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing.Semantic proximity Read ↗

Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.Semantic proximity Read ↗

Comprehensive genomic profile of cholangiocarcinomas in ChinaSemantic proximity Read ↗

Characterization of EGFR family gene aberrations in cholangiocarcinomaSemantic proximity Read ↗

Molecular Pathogenesis and Regulation of the miR-29-3p-Family: Involvement of ITGA6 and ITGB1 in Intra-Hepatic CholangiocarcinomaSemantic proximity Read ↗

Immune checkpoint inhibitor-related molecular markers predict prognosis in extrahepatic cholangiocarcinoma.Semantic proximity Read ↗

Mutational landscape of intrahepatic cholangiocarcinoma.Semantic proximity Read ↗

Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinomaSemantic proximity Read ↗

Genomic and transcriptomic profiling reveals key molecules in metastatic potentials and organ-tropisms of hepatocellular carcinoma.Semantic proximity Read ↗

Integrative Identification and Validation of Exosome-Related Genes as Diagnostic Biomarkers and Potential Therapeutic Targets in CholangiocarcinomaSemantic proximity Read ↗

Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.